Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA)

Neuroscience Letters

Volumn 491, Issue 3, 2011, Pages 202-206

  De Miranda, Aline Silva ^a   Lacerda Queiroz, Norinne ^a   de Carvalho Vilela, Márcia ^a   Rodrigues, David Henrique ^a   Rachid, Milene Alvarenga ^a   Quevedo, João ^b   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Anxiety like behavior; Cerebral malaria; Elevated plus maze; Inflammatory cytokines

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN; BRAIN MALARIA; BRAIN STEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOM;

ANIMALS; ANXIETY; BRAIN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI;

EID: 79951772639     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.038     Document Type: Article

References (30)

1. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 1999, 461:199-233.
2. Armah H., Wiredu E.K., Dodoo A.K., Adjei A.A., Tettey Y., Gyas R. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int. J. Environ. Res. Public Health 2005, 2:123-131.
3. Brown H., Turner G., Rogerson S., Tembo M., Mwenechanya J., Molyneux M., Taylor T. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 1999, 180:1742-1746.
4. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998, 84:923-933.
5. Cragnolini A.B., Schiöth H.B., Scimonelli T.N. Anxiety-like behavior induced by IL-1b is modulated by a-MSH through central melanocortin-4 receptors. Peptides 2006, 27:1451-1456.
6. De Souza J.B., Riley E.M. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 2002, 4:291-300.
7. Desruisseaux M.S., Gulinello M., Smith D.N., Lee S.C., Tsuji M., Weiss L.M., Spray D.C., Tanowitz H.B. Cognitive dysfunction in mice infected with plasmodium berghei strain ANKA. J. Infect. Dis. 2008, 197:1-7.
8. Dugbartey A.T., Dugbartey M.T., Apedo M.Y. Delayed neuropsychiatric effects of malaria in Ghana. Nerv. Ment. Dis. 1998, 186:183-186.
9. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav. Brain Res. 2001, 125:151-157.
10. Grau G.E., Piguet P.F., Engers H.D., Louis J.Á., Vassali P., Lambert P.H. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 1986, 137:2348-2354.
11. Hunt N.H., Golenser J., Chan-Ling T., Parekh S., Potter C.R.S., Medana I.M., Miu J., Ball H.J. Immunopathogenesis of cerebral malaria. Int. J. Parasitol. 2006, 36:569-582.
12. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
13. Idro R., Jenkins N.E., Newton C.R.J.C. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005, 4:827-840.
14. Jennings V.M., Actor J.K., Lal A.A., Hunter R.L. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 1997, 65:4883-4887.
15. John C.C., Opoka R.O., Byarugaba J., Idro R., Boivin M.J. Low levels of RANTES are associated with mortality in children with cerebral malaria. J. Infect. Dis. 2006, 194:837-845.
16. John C.C., Panoskaltsis-Mortari A., Opoka R.O., Park G.S., Orchard P.J., Jurek A.M., Idro R., Byarugaba J., Boivin M.J. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am. J. Trop. Med. Hyg. 2008, 78:198-205.
17. Koo J.W., Duman R.S. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci. Lett. 2009, 456:39-43.
18. Kossodo S., Monso C., Juillard P., Velu T., Goldman M., Grau G.E. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 1997, 91:536-540.
19. Lacerda-Queiroz N., Rodrigues D.H., Vilela M.C., Miranda A.S., Amaral D.C.G., Camargos E.R.S., Carvalho L.J.M., Howe C.L., Teixeira M.M., Teixeira A.L. Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice. Exp. Parasitol. 2010, 125:271-278.
20. Lackner P., Beer R., Heussler V., Goebel G., Rudzki D., Helbok R., Tannich E., Schmutzhard E. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol. Appl. Neurobiol. 2006, 32:177-188.
21. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 1999, 818:291-303.
22. Lyke K.E., Burges R., Cissoko Y., Sangare L., Dao M., Diarra I., Kone A., Harley R., Plowe C.V., Doumbo O.K., Sztein M.B. Serum levels of the proinflammatory cytokines Interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor Alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 2004, 72:5630-5637.
23. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
24. Lou J., Lucas R., Grau G.E. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 2001, 14:810-820.
25. Medana I.M., Hunt N.H., Chaudhri G. Tumor necrosis factor-α expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am. J. Pathol. 1997, 150:1473-1486.
26. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
27. Reis P.A., Comim C.M., Hermani F., Silva B., Barichello T., Portella A.C., Gomes F.C., Sab I.M., Frutuoso V.S., Oliveira M.F., Bozza P.T., Bozza F.A., Dal-Pizzol F., Zimmerman G.A., Quevedo J., Castro-Faria-Neto H.C. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. Plos Pathog. 2010, 6:1-16.
28. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
29. Swiergiel A.H., Dunn A.J. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 2007, 86:651-659.
30. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007, 2:322-328.